Rigel Pharmaceuticals | Ordinære Aksjekapital

Ordinary Share Capital Endring Dato
Amgen USD 32.75B 152M 2023-09
Arrowhead Research USD 200K 0 2023-12
AstraZeneca USD 387M 0 2023-09
Celldex Therapeutics USD 56K 9K 2023-12
Eli Lilly USD 593.6M 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Ligand Pharmaceuticals USD 18K 0 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
Pfizer USD 478M 0 2023-09
Regeneron Pharmaceuticals USD 102K 0 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
Veracyte USD 73K 0 2023-09



Rigel Pharmaceuticals Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.